Financial Performance - The company's operating revenue for 2022 was ¥1,162,627,690.56, a decrease of 7.79% compared to ¥1,260,831,976.72 in 2021[26]. - The net profit attributable to shareholders was -¥278,424,533.43, representing a decline of 703.03% from a profit of ¥46,171,031.16 in the previous year[26]. - The cash flow from operating activities was ¥25,876,824.30, down 83.11% from ¥153,243,763.30 in 2021[26]. - The basic and diluted earnings per share were both -¥0.3005, a decrease of 679.00% compared to ¥0.0519 in 2021[26]. - Total assets at the end of 2022 were ¥2,490,346,685.37, an 8.20% decrease from ¥2,712,784,671.26 at the end of 2021[26]. - The net assets attributable to shareholders decreased by 21.30% to ¥1,006,236,659.41 from ¥1,278,519,957.81 in 2021[26]. - The company reported a significant loss from non-operating activities, with a total of -¥59,256,254.79 in 2022 compared to a gain of ¥17,399,019.11 in 2021[32]. - The company faced uncertainty regarding its ability to continue as a going concern, as indicated by the negative net profit for the last three accounting years[26]. Business Operations - The company has undergone changes in its business scope, now including health management consulting and medical enterprise management consulting[24]. - The company has no changes in its controlling shareholders[24]. - The company’s financial report is guaranteed to be true, accurate, and complete by its management team, including the CEO and accounting heads[4]. - The company operates a comprehensive procurement, production, and sales system, with a centralized procurement model and long-term contracts with key suppliers[47]. - The company has developed three main product lines in the health and wellness sector, focusing on vibrant seniors and specialized care for those with dementia or disabilities[51]. - The company has invested in various medical institutions, including hospitals and clinics, to expand its healthcare services[53]. - The company’s investment properties cover approximately 150,000 square meters in Shanghai, primarily leased to logistics companies[54]. - The company is actively responding to government policies on energy-intensive industries, achieving multiple indicators that meet national standards for energy conservation and emissions reduction[39]. Market Trends and Challenges - The real estate development investment in China decreased by 10% in 2022, reflecting broader industry challenges that may impact the company's performance[36]. - The company's tile business revenue was 974 million yuan, a year-on-year decrease of 10.61%, aligning with the overall industry trend[37]. - The actual production of ceramic tiles in 2022 was approximately 7.3 billion square meters, a year-on-year decline of 10.5%, with a capacity utilization rate of about 73%[37]. - The construction materials industry saw a revenue decline of 4.2% and a profit drop of 20.4% year-on-year in 2022, indicating a worsening trend[37]. - The prices of key raw materials and energy sources, such as natural gas and various minerals, have significantly increased, impacting production costs[44]. - The company faces risks from energy conservation policies, as the building ceramics industry is classified as a heavily polluting sector, necessitating ongoing investment in energy-saving technologies[112]. - Rising prices of raw materials and energy pose a risk to profit margins, with the company implementing annual procurement plans to mitigate cost increases[112]. Product Development and Innovation - In 2022, the company launched new large-format glass-ceramic products, including "Colorful Gem," "Golden Cave Stone," and "Morandi Series," enhancing product quality with features like high strength and low water absorption[46]. - The company is developing a new series of large-format polished tiles aimed at high-end retail markets, with a goal of achieving a good yield rate of over 85%[81]. - The introduction of new product lines, such as the "skin glaze" series, aligns with current market trends and enhances the company's brand image[83]. - The company launched over 40 new products in 2022, with new product sales accounting for nearly 18% of total revenue[57]. Strategic Initiatives - The company is planning to transform its 560 acres of industrial land into an innovative industrial cluster focused on smart medical research and development[64]. - The company is developing a vocational school in Wenzhou to train professionals in the health and wellness sector, expected to open in September 2023[62]. - The company is focusing on expanding its market presence in county and town markets, targeting new growth areas following urban renovation initiatives[109]. - The company aims to expand its channels for old community renovations and elderly-friendly modifications, capitalizing on government initiatives for urban renewal[108]. - The company is committed to promoting customized marketing strategies to enhance product value and meet user demands[109]. Management and Governance - The company has maintained a stable management team, with no significant changes in senior management roles during the reporting period[123]. - The company’s board of directors includes members with extensive backgrounds in finance and management, enhancing its strategic decision-making capabilities[125][126][127][128]. - The company’s financial leadership includes a CFO with experience in both auditing and financial management, contributing to robust financial oversight[126]. - The company has established a governance structure with a board of directors, supervisory board, and various committees to ensure effective decision-making and oversight[158]. - The company’s independent directors have been in place since 2017, ensuring governance and oversight[123]. Environmental Responsibility - The company has a valid pollution discharge permit effective until October 16, 2027, ensuring compliance with environmental regulations[165]. - The company has implemented measures to manage and control environmental factors related to its production activities, ensuring compliance with pollution discharge standards[164]. - Jiangxi Smick's total emissions for smoke dust were 3.473 tons, well below the approved limit of 31.24 tons per year, achieving compliance[166]. - Jiangxi Smick's SO2 emissions were 25.869 tons, significantly under the approved limit of 35.21 tons per year, also meeting standards[166]. - Jiangxi Smick's NOX emissions reached 51.052 tons, well within the approved limit of 105.36 tons per year, indicating compliance[166]. - The company has implemented a comprehensive environmental management system, certified by a third party, ensuring ongoing compliance and transparency[176]. Employee Development - The total number of employees at the end of the reporting period was 920, with 622 from the parent company and 298 from major subsidiaries[150]. - The company conducted a total of 16 training sessions in 2022, enhancing employee skills and supporting distributors[153]. - The company organized nearly 30 training sessions related to elderly care business, with over 400 participants[153]. - The company emphasizes performance management and salary optimization to align employee compensation with company development[151].

（问题征集专题页面二维码） 本公司及董事会全体成员保证公告内容的真实、准确和完整，不存在虚假记 载、误导性陈述或者重大遗漏。 上海悦心健康集团股份有限公司（以下简称"公司"）于 2023 年 3 月 18 日披 露了《2022 年年度报告全文及摘要》。为便于广大投资者进一步了解公司的经营 情况，公司定于 2023 年 3 月 23 日（星期四）15:00－17:00 举办 2022 年度业绩说 明会。本次年度业绩说明会将采用网络远程的方式举行，投资者可登陆全景网"投 资者关系互动平台"（http://ir.p5w.net）参与本次年度业绩说明会。 出席本次业绩说明会的人员有董事长李慈雄先生、总裁余璟先生、财务负责人 赵一非先生、董事会秘书程梅女士、独立董事唐松莲女士。 为充分尊重投资者、提升交流的针对性，现就公司 2022 年度业绩说明会提前 向投资者公开征集问题，广泛听取投资者的意见和建议。投资者可于 2023 年 3 月 22 日（星期三）17:00 前访问全景网（http://ir.p5w.net/zj/）或扫描下方二维 码，进入问题征集专题页面。公司将在 2022 年度业绩说明会上，对投资者普遍关 注 ...

Group 1: Company Collaboration and Product Development - The company signed a brand licensing agreement with Disney in March 2014, allowing the use of Disney cartoon patterns on its tile products. New Disney-themed tile products have been developed [1] - The impact of the Shanghai Disney theme park's construction on the company's sales is expected to be minimal [1] Group 2: Health Board Production and Market Development - The health board market is still in its early development stage, with risks of over-investment leading to idle capacity if production is initiated too early [2] - Currently, the company primarily uses OEM production to meet sales demands, with plans to accelerate factory and production line construction once market demand is released [2] Group 3: Health Board Features and Applications - The self-developed health board has functions such as fresh air purification, formaldehyde removal, and low radiation, mainly used for indoor ceilings and wall decoration, making it an excellent eco-friendly material for home decoration [2] Group 4: Financial Planning from Subsidiary Equity Transfer - Approximately 150 million yuan from the sale of Shanghai Ceramics equity will be used to repay debts owed to Shanghai Ceramics, with a net inflow of about 30 million yuan from the transfer [2] - The transfer of Shanghai Ceramics was primarily to dispose of idle assets, as the production line has been relocated to Jiangxi [2]

Group 1: Company Overview and Strategic Planning - Shanghai SMIK Holdings Co., Ltd. held a targeted investor research event on August 13, 2015, with over 40 participating institutions and individual investors [3] - The company introduced its overall strategic transformation plan, focusing on the development of the health industry [4] - The health medical industry plan was discussed, covering prevention, treatment, and rehabilitation aspects [4] Group 2: Investment and Financial Strategies - The company signed a strategic cooperation and capital increase agreement with Xingshan Insurance Agency, committing to invest RMB 45 million in three phases, aiming to hold a 20% stake in the company post-investment [5] - The company plans to expand its business into the health environment technology sector, transitioning from its existing health board operations [5] Group 3: Subsidiary Developments - The president of Shanghai Yueshen Anyi Investment Management Co., Ltd. presented the elderly care industry plan, detailing product and service offerings, investment pathways, and development strategies [4] - The establishment of a wholly-owned subsidiary, Shanghai SMIK Health Environment Technology Co., Ltd., was initiated in December 2014 to support the transition to health environment technology [5]

悦心安颐商业模式 "安 ' ' | 1 业务模式 — 产品及服务 • 悦心安颐养老社区产品分为以下三种服务模式： | --- | --- | --- | |----------------------------------|--------------------------------------------------------|------------------------------------------------------------------------------| | 老年公寓 | 医养结合社区 | 大型持续照料退休社区 | | 活力及独立老年生活公寓 餐饮服务 | 依托悦心健康投资建设的二 级医院及康复医院而设立的 机构 | 可容纳 1000 户以上老年人居 住的社区，设有独立的会所 包括餐厅、咖啡厅、健身中 | | 家政服务 | 老年术后康复 | 心、礼堂、医疗中心、游泳 | | 交通服务 | | 池、美容院、银行及商店等 | | 生活 / 活动服务 | 阿茨海默氏症记忆护理中心 半自理以及专业照护 | 服务内容包含了老年公寓 与医养结合社区的内容 | | 24 小时保安及紧 ...

Group 1: Market Overview - The scale of China's health industry is projected to reach $3.2 trillion by 2016, with an annual growth rate of approximately 15% [7] - The aging population is increasing, with the proportion of individuals aged 65 and over rising significantly in both mainland China and Taiwan [14] Group 2: Strategic Intent - The company aims to establish a trusted health service platform targeting the one hundred million middle-class individuals in China [22] - The focus is on integrating resources from both sides of the Taiwan Strait to enhance healthcare services [19] Group 3: Operational Strategy - The transformation strategy includes three key points: service chain integration, light asset operation, and cross-strait service integration [26][30] - Emphasis on quality service and long-term profitability while avoiding excessive investment [30] Group 4: Service Offerings - The health service chain encompasses prevention, treatment, rehabilitation, and elderly care [44] - The company plans to establish a rehabilitation hospital in partnership with local government, covering an area of approximately 20,000 square meters [52] Group 5: Leadership and Expertise - The chairman, Chiu Wen-Da, has extensive experience in healthcare management and has held significant positions in Taiwan's health administration [35] - The advisory team includes experts in reproductive medicine and elderly care, enhancing the company's service capabilities [37][42]

Group 1: Market Opportunity - The U.S. health industry has an average annual growth rate of approximately 4%, expected to reach $3.7 trillion by 2020, while China's health industry is projected to grow at about 15%, reaching $3.2 trillion in 2016, making it the largest globally [3] - In 2011, the per capita health-related expenditure in the U.S. was $100, compared to only $7 in China, indicating significant growth potential for China's health industry [4] - Currently, only about 6% of China's total health expenditure is allocated to health services, compared to 17% in the U.S., highlighting a vast growth space [4] Group 2: Strategic Focus Areas - The company aims to build a trusted health platform, focusing on terminal services, including treatment, prevention, and elderly care [5] - The company has restructured into four segments: construction ceramics, health environment technology, elderly care, and medical investment management [5] - Key strategic execution focuses on service chain integration, light asset operations, and cross-strait service integration [6] Group 3: Service Model and Operations - The company plans to develop three types of elderly care services: senior apartments, integrated medical and care communities, and large-scale continuous care retirement communities [9] - The elderly care business model includes leasing projects and new construction projects, with a focus on long-term leases and developing proprietary teams [9] - The company emphasizes the importance of quality service and operational efficiency in the elderly care sector, leveraging Taiwan's successful models [15] Group 4: Financial Management and Growth - The company is exploring various funding sources for its transformation and acquisition needs, including traditional refinancing, bank loans, and support from major shareholders [13] - The traditional business has seen improvements in losses, with a focus on balancing sales growth and operational efficiency [13] - The company is committed to ensuring ethical practices in the elderly care sector, emphasizing long-term vision and technical strength [14]